Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL | T.CRDL.W.A

Cardiol Therapeutics Inc. (Cardiol) is a Canada-based clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). The Company's lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is in a Phase II/III study in hospitalized patients testing positive for COVID-19 with a prior history of, or risk factors for, cardiovascular disease. Cardiol has also received clearance from the Food and Drug Administration (FDA) for its investigational new drug (IND) application for a Phase II international trial that investigates the anti-inflammatory and anti- fibrotic properties of CardiolRx in patients with acute myocarditis, which is a common cause of sudden cardiac death in people under 35 years of age. In addition, Cardiol is developing a subcutaneous formulation of CardiolRx and other anti-inflammatory therapies for the treatment of chronic heart failure.


TSX:CRDL - Post by User

Comment by oracleofkingston Nov 25, 2020 7:40pm
116 Views
Post# 31975528

RE:LOL SH killed it service

RE:LOL SH killed it service
what are you talking about? Here are the facts: Crdl is generating revenue from Shoppers Drug Mart Sales. An FDA approved treatment is only months away. Even with a CoVid vaccine there is still a need for Crdl's treatment. Heart Disease is still one of the leading causes of death in the world and Cardiol is developing a feasible treatment to reduce its impact and increase longevity, especially in the US, the world's largest market for this type of product. In <8 months we will have a listing on the nasdaq which will increase interest in this stock and increase share price. anyone who is skiddish here doesn't understand the fundamentals of this company's value proposition and the potential market size of it's product. months="" we="" will="" have="" a="" listing="" on="" the="" nasdaq="" which="" will="" increase="" interest="" in="" this="" stock="" and="" increase="" share="" price.="" anyone="" who="" is="" skiddish="" here="" doesn't="" understand="" the="" fundamentals="" of="" this="" company's="" value="" proposition="" and="" the="" potential="" market="" size="" of="" it's="" product.="">
<< Previous
Bullboard Posts
Next >>